Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Jul 2022 11:25

RNS Number : 2769U
Maven Income and Growth VCT 3 PLC
29 July 2022
 

Maven Income and Growth VCT 3 PLC

 

Interim Results for the Six Months Ended 31 May 2022

 

Highlights

 

• NAV total return at 31 May 2022 of 151.20p per share

 

• NAV at 31 May 2022 of 57.28p per share, after payment of dividends totalling 3.50p per share during the period

 

• Interim dividend of 1.25p per share declared

 

• Offer for Subscription closed raising £16 million, with a new share issue to be launched during Autumn 2022

 

• Four new private companies added to the portfolio, with a further three completed after the period end

 

• Five profitable private company realisations completed during the period, including the exit from Quorum Cyber, which achieved a total return of 6.5x cost over the life of the investment

 

Overview

 

Notwithstanding inflationary pressures and the economic uncertainty resulting from the crisis in Ukraine, your Company has made positive progress during the first half of the financial year. Whilst the majority of the companies within the portfolio have continued to deliver revenue growth and achieve commercial milestones, NAV total return at the period end has reduced modestly compared to the position at the previous year end. This reflects the volatility within listed markets, which has impacted the value of your Company's AIM quoted portfolio. Across the unlisted portfolio there are a growing number of earlier stage companies that are delivering their commercial objectives and achieving scale, which has resulted in uplifts to certain valuations. This has also been a very busy period for realisations, with a number of investee companies attracting acquisition interest from domestic and international buyers. In addition to the exit from Quorum Cyber, which generated a total return of 6.5x cost, a further four profitable private company realisations also completed. In recognition of this exit activity, and the commitment to make regular tax-free distributions, an interim dividend of 1.25p per share has been declared for payment to Shareholders in August 2022.

 

During the reporting period, the impact of the pandemic has gradually receded, enabling most global economies to re-open, with activity initially recovering in response to pent up demand. However, the invasion of Ukraine has had a destabilising impact on economic growth, with financial markets and commodity prices expected to remain volatile. Furthermore, as global prices, particularly energy costs, continue to rise, high inflation is likely to remain a persistent feature and within the UK the impact of the cost-of-living crisis is still to take full effect. It is, however, worthwhile noting that your Company maintains a low level of direct exposure to consumer facing sectors such as travel, retail, leisure and hospitality, with the investment strategy focused primarily on defensive areas such as software, cybersecurity, data analytics and healthcare, where investee companies with exposure to these sectors have continued to report good growth. This approach to portfolio composition should provide a degree of insulation against the wider inflationary pressures. It is also important to note that, as a result of the considered approach taken by Maven in structuring new investments, the level of external debt across the portfolio is low, which mitigates the risk of further near term interest rate rises. The Manager will continue to monitor the impact of the economic situation on your Company's investment strategy and will maintain a regular dialogue with investee companies, offering assistance with any specific issues that may arise.

 

Against this backdrop, your Company has made further strategic progress. Following the successful fund raising, which closed at the end of May 2022 having raised £16 million, net asset value at the period end increased to £58 million. The new capital provides your Company with sufficient liquidity to enable it to continue to expand and develop the portfolio in line with the objective of building a large and sectorally diversified portfolio of private and AIM quoted companies, which have the potential to achieve scale and generate a capital gain on exit. Throughout the period, the Manager has continued to see good levels of demand for equity investment from ambitious, growth focused businesses across all of its regional offices. In addition to the four new private company holdings added to the portfolio during the period, there is a strong pipeline of potential investments, across a wide range of sectors, at various stages of due diligence and legal process, which should result in a healthy rate of new investment activity during the second half of the financial year. Maven retains a selective approach to investment and continues to favour companies that operate in defensive or counter cyclical sectors and will generally only invest where meaningful commercial traction and strong revenue growth can be demonstrated. This is often measured in terms of contracted annual recurring revenue (ARR), which provides a degree of visibility on the growth trajectory and, given its recurring nature, can provide some protection during a period of economic instability. It is encouraging to report that many of the earlier stage private companies have continued to deliver sustained revenue growth during the period under review which, in certain cases, has merited an uplift in valuation to reflect the progress that has been achieved.

 

Over recent years, as part of the broader investment strategy, your Company has been gradually increasing its exposure to AIM with the objective of constructing a diversified portfolio that is balanced between earlier stage private companies, more mature unlisted holdings and AIM quoted companies. The Manager believes that selective exposure to AIM provides access to a wider range of growth companies, often with more favourable liquidity characteristics, that can provide exposure to dynamic and complementary sectors such as new battery technology, renewable energy, biotech or medtech. Notwithstanding the current market volatility, the Manager continues to see good long term growth potential. Whilst most of the AIM portfolio holdings have continued to issue reassuring market announcements during the reporting period, the overall performance of this portfolio has been impacted by the general volatility that has affected financial markets since the turn of the year.

 

During the period, five profitable private company exits completed, including the most significant exit to date from the early stage portfolio with the sale of Quorum Cyber, which achieved a 6.5x money multiple return inclusive of a retained minority holding. The Manager is encouraged by the level of external interest in the unlisted portfolio, where a number of companies have received approaches from potential buyers that recognise the strategic value within these businesses. As the early stage portfolio matures, the Manager is gaining greater clarity on the holdings that have the potential to drive future growth in Shareholder value. Conversely, there are a small number of cases where the Manager has elected to seek an exit earlier than anticipated as the necessary scale was unlikely to be achieved.

 

During the period under review, your Company completed three investments in companies that have particularly strong environmental, social and governance (ESG) credentials, and which are demonstrating good growth in new and expanding markets. Liftango, which has developed a technology platform to improve the efficiency of on-demand transport such as corporate buses and carpooling, in order to reduce carbon footprint and congestion; Pura, which has developed a range of eco-friendly baby nappies and wipes that are completely plastic free and biodegradable, as well as being accredited by Allergy UK and the British Skin Foundation; and iPac a designer and manufacturer of bespoke sustainable plastic packaging for the UK food sector. ESG considerations are becoming an increasingly important feature of investment and can also be key for potential future acquirers. Further details on the Manager's approach to ESG can be found under Environmental, Social and Governance (ESG).

 

Interim Dividend

 

Following the recent exit activity, in respect of the year ending 30 November 2022, an interim dividend of 1.25p per share will be paid on 26 August 2022 to Shareholders on the register as at 29 July 2022. Since the Company's launch, and after receipt of this interim dividend, 95.17p per share will have been distributed in tax-free dividends. It should be noted that payment of a dividend reduces the NAV of the Company by the total cost of the distribution.

 

Dividend Policy

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the realisation of capital gains, the adequacy of distributable reserves, the availability of surplus revenue and the VCT qualifying level, all of which are kept under close and regular review.

 

The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the considerations outlined above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end.

 

The Directors would like to remind Shareholders that, as the portfolio continues to expand and a greater proportion of holdings are invested in younger companies, the timing of distributions will be more closely linked to realisation activity, whilst also reflecting the Company's requirement to maintain its VCT qualifying level. If larger distributions are required as a consequence of significant exits, this will result in a corresponding reduction in NAV per share. However, the Board and the Manager consider this to be a tax efficient means of returning value to Shareholders, whilst ensuring ongoing compliance with the VCT legislation.

 

Dividend Investment Scheme (DIS)

 

Your Company operates a DIS, through which Shareholders can, at any time, elect to have their dividend payments utilised to subscribe for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax relief applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances.

 

Shareholders can elect to participate in the DIS in respect of future dividends, including the interim dividend that is due to be paid on 26 August 2022, by completing a DIS mandate, which must be received by the Registrar (The City Partnership) before 12 August 2022, this being the next dividend election date. The mandate form, terms & conditions and full details of the scheme (including tax considerations) are available from the Company's website at: mavencp.com/migvct3. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com.

 

 

If a Shareholder is in any doubt about the merits of participating in the DIS, or their own tax status, they should seek advice from a suitably qualified adviser.

 

Joint Offers for Subscription

 

On 20 September 2021, your Company, alongside Maven Income and Growth VCT 4 PLC, launched joint Offers for Subscription for new Ordinary Shares, for up to £20 million in aggregate (£10 million for each company) with a combined over-allotment facility of up to £20 million in aggregate (£10 million for each company). Your Company's Offer closed on 27 May 2022 raising a total of £16 million for the 2021/22 and 2022/23 tax years.

 

With respect to the 2021/22 tax year, there were three allotments of new Ordinary Shares. An allotment of 13,603,037 completed on 4 February 2022, with a further allotment of 4,314,618 new Ordinary Shares completing on 23 March 2022 and a final allotment of 4,767,002 new Ordinary Shares completing on 5 April 2022. An allotment of 2,938,136 new Ordinary Shares for the 2022/23 tax year completed on 6 June 2022.

 

This additional liquidity will enable your Company to continue to expand its portfolio by investing in ambitious, growth focused businesses that operate across a broad range of market sectors, and which have the potential to generate a capital gain on exit. It will also ensure that existing portfolio companies can continue to be supported through follow- on funding where there is an ongoing business case that merits further investment. The funds raised will also allow your Company to maintain its share buy-back policy, whilst also spreading costs over a wider asset base, in line with the objective of maintaining a competitive total expense ratio for the benefit of all Shareholders.

 

Further to the announcement of 8 July 2022, the Directors have elected to launch a new Offer in Autumn 2022, which will run alongside Offers by the three other Maven managed VCTs. Full details of the Offers will be included in the forthcoming Prospectus.

 

Portfolio Developments

 

Integrated drug discovery service provider BioAscent Discovery continues to make encouraging progress across all business lines and is maintaining the impressive growth rate achieved during the previous period. Since the Maven VCTs first invested in 2018, the business has averaged a year-on-year growth rate of 120% in its integrated discovery projects, alongside 40% annualised growth for its more established compound storage and management services. It was also named top performing outsourcer for the second year running, and second place overall, in the Alantra Pharma Fast 50, which ranks the UK's fastest growing privately owned pharma and pharma service companies. The near term strategic objective is to expand internationally, and positive discussions are progressing with several prospective clients in North America and Europe. During the pandemic, BioAscent worked as part of a consortium, led by the University of Glasgow, to establish a national COVID-19 testing facility for high-throughput clinical testing. It is pleasing to note that the consortium (Lighthouse Laboratory) was recently awarded the Knowledge Exchange/Transfer Initiative of the Year at the Times Higher Education (THE) Awards 2021.

 

During the period under review, Bright Network has continued to make good commercial progress and is trading ahead of plan. The business, which utilises a powerful technology database to provide a membership network that enables UK based university undergraduates and recent graduates to connect with leading employers, has built a strong market position. Bright Network offers a comprehensive range of services, including providing advice and support to assist members through their job or internship search process, as well as bespoke in-person networking events. The platform currently has over 600,000 members, with diversity and inclusion being actively monitored and promoted. The business works with over 300 partner firms, including Amazon, Bloomberg, Clifford Chance, Dyson, Google and Vodafone, and the platform is endorsed by organisations such as the CBI, the Department for Work & Pensions and the Institute of Student Employers. Over the coming year, Bright Network will focus on expanding its market position and enhancing its services, with a view to entering specific overseas territories.

 

Fintech specialist Delio has made encouraging commercial progress, and continues to grow its customer base and increase ARR. The business, which is based in Cardiff, designs and develops digital private asset infrastructures for global financial institutions, such as angel networks, family offices and wealth managers, with a growing current client base that includes Barclays, Coutts, Rabobank and the UK Business Angels Association. Its white label platform provides a secure, compliant and efficient system for connecting investors and capital with private market investment opportunities. The business currently has over £26 billion of live deals on its platform and has added further new clients, which has generated further growth in ARR. In February 2022, Delio secured significant additional investment from another institutional investor, with the Maven VCTs also participating. The funding is being used to accelerate product innovation and to help establish a business presence in the US, which is regarded as a key growth market.

 

During the reporting period, analytical software provider e.fundamentals has continued to make positive commercial progress, delivering further growth in ARR and expanding its client base. The business, which provides digital shelf analytics to major consumer packaged goods brands, helps clients to measure and optimise their ecommerce performance to ensure that they maximise an online listing. Over the past two years, e.fundamentals has experienced rapid growth, consistent with the acceleration in online grocery and household shopping during the pandemic, which has resulted in a 600% increase in ARR. e.fundamentals continues to add clients and has established a credible list that includes well known brands such as Arla, Kellogg's, Mars, PepsiCo, Royal Canin and Vodafone.

 

Horizon Ceremonies has delivered strong operational and strategic progress since your Company first invested in 2017 and now has a portfolio of three operational crematoria. Trading at the original site in the Clyde Coast and Garnock Valley remains strong and ahead of plan. The second crematorium, in Cannock, Staffordshire, has traded ahead of plan since opening in April 2021, and the management team is working with local funeral directors and undertakers to increase awareness of the service provided. The third crematorium, in the suburbs of Glasgow, opened in mid- December 2021 and is also trading well. There are two further sites in the near term pipeline. The planning appeal process at Oxted in Surrey is ongoing and a planning application at Hooton, near Chester, has been submitted. The medium term strategic objective remains to build a portfolio of modern, technologically advanced crematoria that meet the best environmental standards whilst offering a compassionate service for families, and to sell the business to a trade, private equity or infrastructure acquirer when all sites reach maturity.

 

Since first investment, HR technology platform provider HiveHR has made good commercial progress and has achieved significant growth in ARR through the rapid addition of new clients. Employee engagement is becoming an increasingly important component of effective management within any organisation. HiveHR's cloud-base SaaS solution offers a comprehensive range of tools and resources that help employers to collate and analyse employee feedback in real time, to enable them to better understand employee concerns or suggestions, and to implement company-wide policy updates or broader change initiatives. HiveHR now has over 170,000 live users, and its clients include Evri, Financial Services Compensation Scheme, Tarmac and Travelodge, as well as a number of universities, housing associations, charities and local authorities. HiveHR is well positioned in a high growth sector and the focus for the year ahead will be to continue to expand the business and accelerate growth in ARR.

 

Marketing technology provider Nano Interactive continues to trade ahead of plan and is delivering against all key performance metrics. The business has established a strong position in the "intent targeting" market, where it uses its proprietary technology to assess multiple intent signals, such as online search history. This analysis enables clients to place adverts in real time, targeting customers that have indicated an interest in a product or service, and helps them enhance the effectiveness of digital advertising campaigns. Importantly, Nano's platform achieves this in an identity-free way, without the use of third party cookies or email addresses, thereby respecting the privacy of online users. The business has made significant progress over the past year and has an extensive client list that includes household names such as Mars, McDonalds, Microsoft, Pets at Home and Vodafone. During 2021, Nano also helped the UK Government to achieve targeted messaging with its COVID-19 communication strategy. Nano is well positioned to achieve further scale and the near term strategic objective is to develop its presence in the US, which should help drive further revenue growth.

 

Language analytics software specialist Relative Insight has maintained an impressive growth rate, increasing ARR and extending its client base. During the period under review, the business secured series B funding from another institutional investor, which provides additional capital to accelerate the growth plan. The business has experienced strong demand for its AI-powered advanced linguistics technology platform, which enables clients to analyse any source of text data and then create content that is designed to appeal to a specific audience to increase the effectiveness of advertising and marketing campaigns. The software solution has been adopted by numerous blue chip names such as Amazon, John Lewis, Nespresso and Sky, alongside large marketing and advertising agencies. Following the recent fund raising, the business is capitalised to deliver further growth and has the medium term objective of establishing a presence in the US.

 

During the period, Rockar, a developer of a disruptive digital platform for buying new and used cars, has continued to grow its market presence and build commercial relationships with global car manufacturers and national dealership groups that are keen to develop a digital alternative to replace or complement the traditional showroom model. Following the demerger of the retail business in May 2021, the business is now focused exclusively on developing and expanding its technology platform and is currently working on projects with manufacturers such as BMW and Jaguar Land Rover, and is progressing discussions with several others. Over the past year, there has been a rapid acceleration in the move to digitise the automotive market, which has been one of the few remaining major retail sectors to fully embrace a technological solution. There are now a number of high profile companies operating in this space and Rockar remains at the forefront in terms of its technological capabilities and sector experience.

 

Whilst the majority of companies within the portfolio have made encouraging progress in the year to date, there are a small number that have not achieved commercial objectives and where the value of the holding has been written down. Speciality industrial services provider Cat Tech experienced a particularly challenging operating environment during the pandemic, as international travel restrictions prevented the completion of scheduled maintenance programmes in its overseas territories. Whilst Cat Tech provides highly specialist services that are a health and safety requirement, the ongoing travel disruption, coupled with deferred shutdowns at key client sites, has resulted in the scheduled programme of works being delayed. Trading in the current year is expected to be below budget and a provision has been taken against the value of the holding. In addition, a full write down has been taken against the value of the holding in Boiler Plan, which experienced challenging trading during the pandemic and has subsequently failed to deliver its business plan.

 

Liquidity Management

 

The Board and the Manager continue to operate an active liquidity management policy, with the objective of generating income from cash resources held prior to investment. The Manager has constructed a focused portfolio of listed investment trust holdings and will continue to consider any other permitted investment options that have the potential to meet this objective.

 

New Investments

 

During the period, four new VCT qualifying private companies were added to the portfolio:

 

CYSIAM is a provider of cybersecurity and incident response services to a broad range of public and private sector clients. The company provides specialist advice and bespoke training, and also offers a wraparound managed service solution for clients seeking to fully outsource their cybersecurity function. The founders have significant experience of critical defence and national security environments, both in the UK and overseas, and a deep understanding and personal insight into this rapidly expanding speciality market. The VCT funding is being used to support the business as it launches a sales and marketing campaign to raise the corporate profile, as well as providing capital to progress further product development.

 

iPac is an established designer and manufacturer of bespoke sustainable thermoformed plastic packaging that is used by the food and pharmaceutical sectors. The business is at the leading edge of sustainable manufacturing and its products are 100% recyclable and use over 85% recycled content. The manufacturing plant is powered entirely through renewable sources and less than 2% of manufacturing waste goes into landfill. The VCT funding is being used to develop new product lines, which are more efficient and produce less waste, and to open a second manufacturing facility in the North East of England.

 

Liftango is a provider of a demand responsive transport (DRT) technology platform, which enables clients such as governments, transport authorities and global corporates to optimise route planning in real-time in response to passenger usage. The business has three core products (on-demand buses, fixed-route shuttles and carpool), all of which are designed to optimise vehicle scheduling and routing to improve fleet efficiency. The technology also helps clients to minimise carbon footprint, reduce congestion and create a safe and convenient shared transport network. Liftango has a strong client list, including corporates such as IKEA, Tesla, Unilever and Volvo, as well as several county councils. The VCT funding is being used to recruit key sales and marketing staff, and to assist the business as it expands into Europe and North America.

 

Pura is a baby care brand that specialises in eco-friendly wipes and nappies. Pura's plant-based wipes are 100% plastic free and biodegradable, as well as being accredited by Allergy UK and the British Skin Foundation, while the nappies are enhanced with organic cotton and made using green energy with no production waste to landfill. Since launching in 2020, Pura has established itself through a direct-to-consumer, subscription-based website model and has gained recognition within its core target market, with its eco-friendly nappies recently awarded Gold in the Made for Mums Awards 2022. The VCT funding is being used to support the expansion into the business- to-business market, which is specifically targeted at the UK and US supermarket sectors. Pura has already made good progress in this area, having secured contracts with Amazon, Costco and Ocado, with the brand also recently launching in Asda.

 

During the reporting period, the following investments were completed:

 

 

 

Investments

 

 

Date

 

 

Sector

Investment

cost

£'000

New unlisted

 

 

 

CYSIAM Limited

December 2021

Software

199

Kanabo GP Limited1

February 2022

Pharmaceuticals, biotechnology & healthcare

1,611

Liftango Group Limited

December 2021

Software

298

mypura.com Group Limited (trading as Pura)

January 2022

Business services

216

Project Falcon Topco Limited (trading as Quorum Cyber)2

December 2021

Software

335

Reed Thermoformed Packaging Limited (trading as iPac)

March 2022

Business services

99

Total new unlisted

 

 

2,758

 

 

Follow-on unlisted

 

 

 

Boiler Plan (UK) Limited

February 2022

Business services

38

e.fundamentals (Group) Limited

January 2022

Marketing & advertising technology

75

HiveHR Limited3

March & April 2022

Software

17

MirrorWeb Limited

May 2022

Software

100

Push Technology Limited

May 2022

Data analytics

100

Shortbite Limited (trading as DigitalBridge)

January 2022

Marketing & advertising technology

50

Total follow-on unlisted

 

 

380

 

 

 

 

Total investments

 

 

3,138

 

1 The holding in this investment resulted from the sale of The GP Service (UK) Limited, which was structured as a share for share exchange.

2 Retained minority interest following the sale of Quorum Cyber Security Limited.

3 Follow-on investment completed in two tranches.

 

At the period end, the portfolio stood at 95 unlisted and quoted investments, at a total cost of £33.7 million.

 

Realisations

 

In December 2021, the sale of online mortgage broker Mojo Mortgages completed following receipt of regulatory approval. Your Company first invested in Mojo in 2019, supporting an ambitious management team to develop its disruptive mortgage broking technology platform. Mojo's solution provides an innovative hybrid of online and advised services, capable of managing the entire process from product price comparison through to the mortgage application and completion. The sale to RVU, which is part of the Zoopla Property Group and owns of a number of consumer finance and comparison sites, generated a total return of up to 1.8x cost (including monies held in escrow) over the life of the investment.

 

Also in December, the sale of cybersecurity technology provider Quorum Cyber completed. The threat of cyber-attacks has become an increasingly significant risk for businesses, which was amplified during the pandemic as companies followed Government advice and implemented working from home practices which, in some cases, exposed system weaknesses. Against this backdrop Quorum, which provides a fully managed, 24/7 cyber risk mitigation platform for corporate clients, experienced a rapid increase in demand for its services which, in turn, resulted in strong growth in revenues. The business increased its customer base through organic growth as well as via referrals from partners such as Microsoft. An approach to acquire Quorum was subsequently received from a UK private equity house and the exit delivered an overall money multiple return of 6.5x cost, inclusive of a retained minority holding in the business. This retained holding enables your Company to participate in the future growth of Quorum, which offers the potential for a further return.

 

In January 2022, the holding in 3D photonic circuit specialist Optoscribe was realised through the sale to a US corporate buyer. Since the Maven VCTs first invested in 2019, the Manager has supported the company's growth through several funding rounds, enabling the business to strengthen strategic partnerships and move into higher volume production. Optoscribe manufactures high-performance photonic integrated circuits for use by optical transceiver manufacturers in the production of glass-based 3D circuits in the telecom, datacom and mobile network markets. Its technology produces components primarily for the cloud data centre sector, which has experienced strong growth as consumer demand increases for access to high quality content. The exit generated a total return of 1.85x cost over the holding period.

 

In early March 2022, the residual holding in Global Risk Partners (Maven Co-invest Endeavour) was provisionally sold to US listed insurance broker Brown & Brown, with regulatory approval received shortly after the period end. The acquisition enables Brown & Brown to establish itself in the UK retail insurance sector, where it does not currently have a large presence. As part of the initial sale of Global Risk Partners to Searchlight Capital Partners in 2020, an element of the sale consideration was reinvested into the acquiring vehicle. The subsequent sale to Brown & Brown has resulted in a full exit from this investment and generated a further return equivalent to 1.24x the original cost, taking the total money multiple return to 3.38x cost.

 

Also in March, the holding in energy services specialist RMEC was realised through the sale to Aberdeen based trade acquirer Centurion Group. Over the holding period, RMEC has delivered a consistently strong performance despite the various challenges within its operating environment. The business traded profitably throughout the pandemic and, during this time, continued to secure blue-chip clients and agree long term master service agreements with key North Sea operators and service companies. The exit achieved a total return of 2.28x cost over the life of the investment, inclusive of all income payments.

 

The table below gives details of all realisations completed during the reporting period:

 

Realisations

 

Year

first

invested

Complete/

partial exit

Cost of

shares

disposed of

£'000

Value at 30

November

2021

£'000

 

Sales

proceeds

£'000

Realised

gain/(loss)

£'000

Gain/ (loss) over

30 November

2021 value

£'000

Unlisted

 

 

 

 

 

 

 

Life's Great Group Limited (trading as Mojo Mortgages)

2019

Complete

979

1,637

1,637

658

-

Optoscribe Limited

2018

Complete

188

407

411

223

4

Quorum Cyber Security Limited1

2020

Complete

400

2,562

2,562

2,162

-

RMEC Group Limited2

2014

Complete

446

724

666

220

(58)

The GP Service (UK) Limited3

2016

Complete

852

884

1,611

759

727

Others

 

 

-

-

7

7

7

Total unlisted

 

 

2,865

6,214

6,894

4,029

680

 

 

 

 

 

 

 

 

Total sales

 

 

2,865

6,214

6,894

4,029

680

 

1 Proceeds exclude yield received, which is disclosed as revenue for financial reporting purposes.

2 Proceeds exclude yield and redemption premium received, which are disclosed as revenue for financial reporting purposes.

3 The holding in The GP Service (UK) Limited was acquired by Kanabo GP Limited, a subsidiary of Kanabo Group PLC, in a transaction that was structured as a share for share exchange. In line with International Private Equity and Venture Capital Valuation (IPEV) guidelines, the value of the holding has been adjusted to reflect the market value of the listed Kanabo shares as at 31 May 2022.

 

During the period, one private company was struck off the Register of Companies, resulting in a realised loss of £300,000 (cost £300,000). This had no effect on the NAV of the Company as a full provision had been made against the value of the holding in a previous period.

 

Material Developments Since the Period End

 

Since 31 May 2022, three new private company holdings have been added to the portfolio:

 

Novatus Advisory is a regulatory advisory business that helps financial organisations prevent or remedy regulatory or compliance issues through the provision of advisory services (both project based and long term assignments) and also provides bespoke regulatory software. The company has a strong client base that includes blue-chip names such as Artemis and Enstar. It recently invested in software development to create a transaction reporting tool to help clients to meet legal reporting requirements and reconcile trades. The VCT funding is being used to progress product development, particularly within the software side of the business.

 

XR Games is a developer of virtual reality (VR) and augmented reality (AR) games, which creates mobile and console-based games under licence as well as providing a work-for-hire studio. Through a licence agreement with Sony Picture, XR has developed the VR game The Angry Birds Movie 2 VR: Under Pressure, which was released for PlayStation and launched alongside the movie Angry Birds 2. More recently, XR produced and developed Zombieland VR, a game based on the film franchise of the same name. XR has become a Microsoft partner, through its relationship with Sony, and is currently working on a number of projects and game prototypes. The business has built a good market reputation and is well positioned to achieve growth in this expanding sector. The VCT funding is being used to support the pipeline of game development, enhance the marketing function and make a number of strategic new hires.

 

Zinc Systems is a provider of a software-based solution for safety, security and critical event management, which currently supports clients in four key sectors: retail, corporate, government, and security and facilities management. Zinc's solution, which provides support for incidents such as fire, online fraud or compliance breaches, is fully integrated with a client's system and configured for mobile access, meaning that critical information is instantly available and remotely accessible. The business has achieved good scale and currently has over 30,000 users in over 20 countries, with a strong client list that includes B&Q, City of London Police and the Environmental Agency. The VCT funding is being used to enhance the sales and marketing function and to progress product development.

 

In July 2022, the holding in e.fundamentals was realised through a sale to CommerceIQ, a US private equity backed trade consolidator. The exit generated a total return on investment of 2.35x cost, comprised of an initial cash return of 1x cost plus an equity stake in the enlarged business, which has the potential to deliver a further return to shareholders in the future.

 

Principal and Emerging Risks and Uncertainties

 

The principal and emerging risks and uncertainties facing the Company were set out in full in the Strategic Report contained within the 2021 Annual Report, and are the risks associated with investment in small and medium sized unlisted and AIM/AQSE quoted companies which, by their nature, carry a higher level of risk and are subject to lower liquidity than investments in larger quoted companies. The valuation of investee companies may be affected by economic conditions, the credit environment and other risks including legislation, regulation, adherence to VCT qualifying rules and the effectiveness of the internal controls operated by the Company and the Manager. These risks and procedures are reviewed regularly by the Audit & Risk Committee and reported to your Board. The Board has confirmed that all tests, including the criteria for VCT qualifying status, continue to be monitored and met.

 

In March 2020, the COVID-19 pandemic developed from being an emerging risk to a principal risk that had implications for the Company, the Manager, investee companies and both the UK and global economies. The Board and the Manager have sought to identify all of the individual risks associated with the pandemic that could impact on the Company and the steps that are required to mitigate them. These have been recorded in separate risk registers that will be reviewed on a regular basis as the situation continues to evolve.

 

During the period, the invasion of Ukraine by Russia was added to the Risk Register as an emerging risk, as the Directors were not only aware of the heightened cyber security risk but were mindful of the impact that a change in the underlying economic conditions could have on the valuation of investment companies, such as fluctuating interest rates, increased fuel and energy costs, and the availability of bank finance, all of which can be impacted during times of geopolitical uncertainty and volatile markets.

 

Share Buy-backs

 

Shareholders will be aware that a primary objective for the Board is to ensure that the Company retains sufficient liquidity for making investments in line with its stated policy, and for the continued payment of dividends. However, the Directors also acknowledge the need to maintain an orderly market in the Company's shares and have, therefore, delegated authority to the Manager to buy back shares in the market, for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders.

 

It is intended that the Company should seek to maintain a share price discount that is approximately 5% below the latest published NAV per share, subject to market conditions, available liquidity, and the maintenance of the Company's VCT qualifying status. During the period under review, 240,360 shares were bought back at a total cost of £138,000.

 

VCT Regulatory Update

 

During the period under review, there have been no further amendments to the rules governing VCTs. The Spring Budget was delivered on 23 March 2022 and did not propose any changes to VCT legislation.

 

The Directors and the Manager continue to apply the International Private Equity and Venture Capital Valuation (IPEV) Guidelines as the central methodology for all private company valuations. The IPEV Guidelines are the prevailing framework for fair value information in the private equity and venture capital industry. In light of the current geopolitical and macroeconomic uncertainty resulting from the conflict in Ukraine, on 31 March 2022, IPEV reiterated the Special Guidance provided in March 2020, with respect to assessing the fair value of private company holdings. The Directors and the Manager continue to follow industry best practice and adhere to the IPEV Special Guidelines in all private company valuations.

 

Environmental, Social and Governance (ESG)

 

As part of a move towards more sustainable investing, the Manager has enhanced its investment appraisal process, with ESG now embedded as a core component within the selection criteria. Additionally, a robust framework has been developed to ensure that ESG considerations are monitored and managed carefully throughout the period of investment.

 

As previously noted, your Company recently completed a number of new investments in companies that have strong ESG credentials and are achieving growth in expanding markets. It is also worthwhile noting that your Company's exposure to the energy services sector has been reducing over recent years. Following the sale of RMEC, this exposure is now only 3% of the portfolio by value, with most remaining investee companies actively diversifying away from traditional oil & gas markets and moving into renewable energy or other adjacent markets to realign their future growth strategy.

 

Outlook

 

Your Company has continued to make positive progress during the first half of the financial year and, following the success of the recent fund raising, has sufficient near term liquidity to enable it to continue to progress its investment strategy. The primary near term challenge is the impact of inflationary pressures and the associated risk of constrained economic growth. Against this background, the Manager will maintain a focused approach in targeting emerging growth companies operating in sectors and markets that are likely to be more resilient and less dependent on discretionary consumer spending.

 

 

 

 

On behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

29 July 2022

 

Summary of Investment Changes

For the six months ended 31 May 2022

 

 

Valuation

30 November 2021

£'000 %

Net investment/ (disinvestment)

£'000

Appreciation/ (depreciation)

£'000

Valuation

31 May 2022

£'000 %

Unlisted investments

 

 

 

 

 

 

Equities

26,728

54.3

(3,158)

1,045

24,615

42.2

Loan stock

8,806

17.9

(577)

(178)

8,051

13.8

 

35,534

72.2

(3,735)

867

32,666

56.0

AIM/AQSE investments*

 

 

 

 

 

 

Equities

 

4,525

9.2

-

(1,946)

2,579

4.4

Listed investments

 

 

 

 

 

Investment trusts

3,351

6.8

-

(299)

3,052

5.2

Total investments

43,410

88.2

(3,735)

(1,378)

38,297

65.6

 

Other net assets

 

 

5,790

 

11.8

 

-

 

14,187

 

19,977

 

34.4

Net assets

49,200

100.0

(3,735)

12,809

58,274

100.0

 

* Shares traded on the Alternative Investment Market (AIM) or the Aquis Stock Exchange (AQSE).

 

 

Investment Portfolio Summary

 

As at 31 May 2022

 

Investment

Valuation

£'000

Cost

£'000

% of

total

assets

% of

equity

held

% of equity held by

other clients1

Unlisted

 

 

 

 

 

Horizon Ceremonies Limited (trading as Horizon Cremation)

1,932

1,288

3.4

8.7

44.0

Bright Network (UK) Limited

1,787

1,015

3.2

8.9

31.0

Relative Insight Limited

1,505

700

2.6

3.8

7.1

e.fundamentals (Group) Limited

1,426

642

2.4

3.8

7.1

Rockar 2016 Limited (trading as Rockar)

1,368

928

2.3

4.8

16.8

Martel Instruments Holdings Limited

1,278

671

2.2

12.4

31.8

Delio Limited

1,246

533

2.1

2.5

9.7

Ensco 969 Limited (trading as DPP)

1,236

1,133

2.1

4.8

29.7

Nano Interactive Group Limited

1,126

625

1.9

3.7

11.2

Vodat Communications Group (VCG) Holding Limited (formerly Vodat Communications Group Limited)

1,024

567

1.8

4.2

22.6

Contego Solutions Limited (trading as NorthRow)

997

997

1.7

8.7

23.5

CB Technology Group Limited

914

558

1.6

11.2

67.7

Filtered Technologies Limited

816

750

1.4

7.6

17.8

WaterBear Education Limited

785

370

1.3

7.8

31.4

Precursive Limited

750

750

1.3

5.4

28.8

Hublsoft Group Limited

750

600

1.3

9.4

21.9

BioAscent Discovery Limited

744

199

1.3

5.0

35.0

Cardinality Limited

668

448

1.1

4.5

20.5

QikServe Limited

658

658

1.1

3.0

12.8

TC Communications Holdings Limited

645

980

1.1

8.3

21.7

Cat Tech International Limited

627

627

1.1

6.0

24.0

Push Technology Limited

625

625

1.1

2.8

8.5

Flow UK Holdings Limited

597

597

1.0

7.0

28.0

MirrorWeb Limited

562

400

1.0

3.4

41.4

Glacier Energy Services Holdings Limited

544

686

0.9

2.6

25.0

HCS Control Systems Group Limited

539

746

0.9

6.1

30.4

Kanabo GP Limited2

509

1,611

0.9

13.5

53.6

Horizon Technologies Consultants Limited

506

448

0.9

3.1

14.1

Maven Co-Invest Endeavour Limited Partnership

499

2

0.9

8.1

91.9

Whiterock Group Limited

485

320

0.8

5.1

24.9

HiveHR Limited

476

317

0.8

4.4

40.2

 

 

 

 

 

 

 

 

 

As at 31 May 2022

 

Investment

Valuation

£'000

Cost

£'000

% of total assets

% of equity held

% of equity held by other clients1

Unlisted (continued)

 

 

 

 

 

CODILINK UK Limited (trading as Coniq)

450

450

0.8

1.3

3.6

GradTouch Limited

400

400

0.7

4.6

35.4

ebb3 Limited

366

326

0.6

6.9

51.7

Project Falcon Topco Limited (trading as Quorum Cyber)3

335

335

0.6

1.0

1.9

Growth Capital Ventures Limited

331

319

0.6

5.8

41.6

The Algorithm People Limited

300

300

0.5

6.3

10.6

Enpal Limited (trading as Guru Systems)

299

299

0.5

3.2

18.4

Liftango Group Limited

298

298

0.5

1.8

12.1

Snappy Shopper Limited

298

298

0.5

0.4

1.4

mypura.com Group Limited (trading as Pura)

216

216

0.4

1.0

17.8

Rico Developments Limited (trading as Adimo)

200

200

0.3

1.5

8.2

Atterley.com Holdings Limited

199

199

0.3

2.5

15.2

Draper & Dash Limited (trading as RwHealth)

199

199

0.3

1.0

12.6

FodaBox Limited

199

199

0.3

1.4

9.4

CYSIAM Limited

199

199

0.3

3.5

16.5

R&M Engineering Group Limited

172

761

0.3

8.3

62.3

ISN Solutions Group Limited

127

321

0.2

4.5

50.5

Shortbite Limited (trading as DigitalBridge)

106

275

0.2

1.0

23.9

RevLifter Limited

100

100

0.2

1.1

19.3

Reed Thermoformed Packaging Limited (trading as iPac)

99

99

0.2

0.6

11.9

Intilery.com Limited

75

75

0.1

0.6

58.6

Honcho Markets Limited

65

64

0.1

1.2

23.5

Other unlisted investments

9

1,092

-

 

 

Total unlisted

32,666

27,815

56.0

 

 

 

 

 

 

 

 

 

 

As at 31 May 2022

 

Investment

Valuation

£'000

Cost

£'000

% of total assets

% of equity held

% of equity held by other clients1

Quoted

 

 

 

 

 

GENinCode PLC

676

598

1.2

3.5

7.5

MaxCyte Inc

294

137

0.6

0.1

0.1

Diaceutics PLC

228

161

0.4

0.3

0.3

C4X Discovery Holdings PLC

195

119

0.3

0.3

0.6

Faron Pharmaceuticals Oy

158

250

0.3

0.1

0.1

ReNeuron Group PLC

131

278

0.2

0.7

1.4

Polarean Imaging PLC

110

129

0.2

0.1

0.5

Crossword Cybersecurity PLC

110

122

0.2

0.5

2.1

Destiny Pharma PLC

102

150

0.2

0.3

1.2

AFC Energy PLC

96

57

0.2

-

-

Pelatro PLC

86

146

0.1

0.7

2.0

Feedback PLC

73

121

0.1

0.5

1.3

Eden Research PLC

58

83

0.1

0.4

1.0

Spectral MD Holdings PLC

57

99

0.1

0.1

0.1

Oncimmune Holdings PLC

53

100

0.1

0.1

0.5

RUA Life Sciences PLC

37

100

0.1

0.4

1.3

Seeen PLC

23

75

-

0.3

1.4

Diurnal Group PLC

23

62

-

0.1

0.4

Vianet Group PLC

21

31

-

0.1

1.4

Osirium Technologies PLC

20

100

-

0.6

3.8

Trackwise Designs PLC

20

27

-

0.1

0.3

DeepMatter Group PLC

8

98

-

0.2

0.4

Other quoted investments

-

584

-

 

 

Total quoted

2,579

3,627

4.4

 

 

 

 

 

As at 31 May 2022

 

Investment

Valuation

£'000

Cost

£'000

% of total assets

% of equity held

% of equity held by other clients1

Private equity investment trusts

 

 

 

 

 

HgCapital Trust PLC

489

249

0.8

-

0.1

ICG Enterprise Trust PLC

425

334

0.7

0.1

0.1

HarbourVest Global Private Equity Limited

413

250

0.7

-

0.1

BMO Private Equity Trust PLC (formerly F&C Private Equity Trust PLC)

327

253

0.6

0.1

0.3

Apax Global Alpha Limited

325

250

0.6

-

0.1

Princess Private Equity Holding Limited

308

270

0.5

0.1

0.1

Pantheon International PLC

252

180

0.4

-

0.1

abrdn Private Equity Opportunities Trust PLC (formerly Standard Life Private Equity Trust PLC)

170

110

0.3

-

0.1

Total private equity investment trusts

2,709

1,896

4.6

 

 

 

 

Real estate investment trusts

 

 

 

 

 

Target Healthcare REIT PLC

103

96

0.2

-

0.1

Schroder REIT Limited

92

107

0.2

-

0.1

Regional REIT Limited

89

101

0.1

-

0.1

Custodian REIT PLC

59

71

0.1

-

-

Total real estate investment trusts

343

375

0.6

 

 

 

 

 

 

 

 

Total investments

38,297

33,713

65.6

 

 

 

1 Other clients of Maven Capital Partners UK LLP.

2 The holding in this investment resulted from the sale of The GP Service (UK) Limited to Kanabo GP Limited in a share for share exchange. In line with IPEV guidelines, the valuation has been adjusted to reflect the market value of the listed Kanabo shares as at 31 May 2022.

3 Retained minority interest following the sale of Quorum Cyber Security Limited.

 

Shaded line indicates that the investment was completed pre 2015.

 

 

Income Statement

 

As at 31 May 2022

 

 

Six months ended

31 May 2022

(unaudited)

Six months ended

31 May 2021

(unaudited)

Year ended

30 November 2021

(audited)

 

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

(Losses)/gains on investments

-

(1,378)

(1,378)

-

5,488

5,488

-

8,550

8,550

Income from investments

435

-

435

302

-

302

755

-

755

Other income

3

-

3

1

-

1

2

-

2

Investment management fees

(132)

(528)

(660)

(263)

(1,054)

(1,317)

(444)

(1,776)

(2,220)

Other expenses

(179)

-

(179)

(138)

-

(138)

(356)

-

(356)

Net return on ordinary activities before taxation

127

(1,906)

(1,779)

(98)

4,434

4,336

(43)

6,774

6,731

 

Tax on ordinary activities

 

(8)

 

8

 

-

 

-

 

-

 

-

 

-

 

-

 

-

Return attributable to Equity Shareholders

119

(1,898)

(1,779)

(98)

4,434

4,336

(43)

6,774

6,731

 

Earnings per share (pence)

 

0.13

 

(2.10)

 

(1.97)

 

(0.13)

 

5.58

 

5.45

 

(0.05)

 

8.54

 

8.49

 

All gains and losses are recognised in the Income Statement.

 

All items in the above statement are derived from continuing operations. The Company has only one class of business and one reportable segment, the results of which are set out in the Income Statement and Balance Sheet. The Company derives its income from investments made in shares, securities and bank deposits.

 

There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Statement of Changes in Equity

 

Six months ended 31 May 2022

 

 

Non-distributable reserves

Distributable reserves

 

Six months ended

31 May 2022

(unaudited)

Share capital

£'000

Share premium account

£'000

Capital

Redemption reserve

£'000

Capital

Reserve unrealised

£'000

Capital reserve realised

£'000

Special

Distributable reserve

£'000

Revenue reserve

£'000

Total

£'000

At 30 November 2021

7,866

6,436

287

9,669

(1,823)

26,020

745

49,200

Net return

-

-

-

(5,085)

3,707

(520)

119

(1,779)

Dividends paid

-

-

-

-

-

(3,299)

-

(3,299)

Repurchase and

(24)

-

24

-

-

(138)

-

(138)

cancellation of shares

Net proceeds of share issue

2,303

11,841

-

-

-

-

-

14,144

Net proceeds of DIS issue

28

118

-

-

-

-

-

146

At 31 May 2022

10,173

18,395

311

(4,584)

1,884

22,063

864

58,274

 

 

 

Non-distributable reserves

Distributable reserves

 

Six months ended

31 May 2021

(unaudited)

Share capital

£'000

Share premium account

£'000

Capital

redemption reserve

£'000

Capital

reserve unrealised

£'000

Capital reserve realised

£'000

Special

distributable reserve

£'000

Revenue reserve

£'000

Total

£'000

At 30 November 2020

7,965

6,285

153

(722)

18

30,332

788

44,819

Net return

-

-

-

6,536

(1,048)

(1,054)

(98)

4,336

Dividends paid

-

-

-

-

-

(794)

-

(794)

Repurchase and

(55)

-

55

-

-

(294)

-

(294)

cancellation of shares

Net proceeds of DIS issue

15

74

-

-

-

-

-

89

At 31 May 2021

7,925

6,359

208

5,814

(1,030)

28,190

690

48,156

 

 

 

Non-distributable reserves

Distributable reserves

 

 

Year ended

30 November 2021

(audited)

Share capital

£'000

Share premium account

£'000

Capital

redemption reserve

£'000

Capital

reserve unrealised

£'000

Capital reserve realised

£'000

Special

distributable reserve

£'000

Revenue reserve

£'000

Total

£'000

At 30 November 2020

7,965

6,285

153

(722)

18

30,332

788

44,819

Net return

-

-

-

10,391

(1,841)

(1,776)

(43)

6,731

Dividends paid

-

-

-

-

-

(1,783)

-

(1,783)

Repurchase and

(134)

-

134

-

-

(753)

-

(753)

cancellation of shares

Net proceeds of DIS issue

35

151

-

-

-

-

-

186

At 30 November 2021

7,866

6,436

287

9,669

(1,823)

26,020

745

49,200

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

 

Balance Sheet

 

As at 31 May 2022

 

 

31 May 2022

(unaudited)

£'000

31 May 2021

(unaudited)

£'000

30 November 2021

(audited)

£'000

Fixed assets

 

 

 

Investments at fair value through profit or loss

38,297

40,139

43,410

Current assets

 

 

 

Debtors

512

392

508

Cash

19,528

8,397

5,648

 

20,040

8,789

6,156

Creditors

 

 

 

Amounts falling due within one year

(63)

(772)

(366)

Net current assets

19,977

8,017

5,790

Net assets

58,274

48,156

49,200

 

Capital and reserves

 

 

 

Called up share capital

10,173

7,925

7,866

Share premium account

18,395

6,359

6,436

Capital redemption reserve

311

208

287

Capital reserve - unrealised

4,584

5,814

9,669

Capital reserve - realised

1,884

(1,030)

(1,823)

Special distributable reserve

22,063

28,190

26,020

Revenue reserve

864

690

745

Net assets attributable to Ordinary Shareholders

58,274

48,156

49,200

Net asset value per Ordinary Share (pence)

57.28

60.76

62.55

 

 

The Financial Statements of Maven Income and Growth VCT 3 PLC, registered number 04283350, were approved by the Board and were signed on its behalf by:

 

 

 

Atul Devani

Director

 

29 July 2022

 

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

 

Cash Flow Statement

 

For the six months ended 31 May 2022

 

 

Six months ended 31 May 2022 (unaudited)

£'000

Six months ended 31 May 2021 (unaudited)

£'000

Year ended

30 November 2021(audited)

£'000

Net cash flows from operating activities

(735)

(458)

(1,574)

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of investments

(1,527)

(1,800)

(3,334)

Sale of investments

5,289

1,176

2,428

Net cash flows from investing activities

3,762

(624)

(906)

 

Cash flows from financing activities

 

 

 

Equity dividends paid

(3,299)

(794)

(1,783)

Issue of Ordinary Shares

14,290

89

186

Repurchase of Ordinary Shares

(138)

(294)

(753)

Net cash flows from financing activities

10,853

(999)

(2,350)

 

 

 

 

Net increase/(decrease) in cash

13,880

(2,081)

(4,830)

 

 

Cash as at beginning of period

 

 

5,648

 

 

10,478

 

 

10,478

Cash at end of period

19,528

8,397

5,648

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

 

Notes to the Financial Statements

 

1. Accounting Policies

 

The financial information for the six months ended 31 May 2022 and the six months ended 31 May 2021 comprises non-statutory accounts within the meaning of S435 of the Companies Act 2006. The financial information contained in this report has been prepared based on the accounting policies set out in the Annual Report and Financial Statements for the year ended 30 November 2021, which have been filed at Companies House and contained an Auditor's Report that was not qualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006.

 

2. Reserves

 

Share premium account

 

The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs. This reserve is non-distributable.

 

Capital redemption reserve

 

The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve. This reserve is non-distributable.

 

Capital reserve - unrealised

 

Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. This reserve is non-distributable.

 

Capital reserve - realised

 

Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on disposal. This reserve is distributable.

 

Special distributable reserve

 

The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account. The special distributable reserve also represents capital dividends, capital investment management fees and the tax effect of capital items. This reserve is distributable.

 

Revenue reserve

 

The revenue reserve represents accumulated profits retained by the Company that have not been distributed to Shareholders. This reserve is distributable.

 

3. Return per Ordinary Share

 

 

Six months ended 31 May 2022

The returns per share have been based on the following figures:

Weighted average number of Ordinary Shares

90,438,570

Revenue return

£119,000

Capital return

(£1,898,000)

Total return

(£1,779,000)

 

Directors' Responsibility Statement

 

Each Director believes that, to the best of their knowledge:

 

• the Financial Statements for the six months ended 31 May 2022 have been prepared in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland;

 

• the Interim Management Report includes a fair review of the information required by DTR 4.2.7R in relation to the indication of important events during the first six months, and of the principal and emerging risks and uncertainties facing the Company during the second six months, of the year ending 30 November 2022; and

 

• the Interim Management Report includes adequate disclosure of the information required by DTR 4.2.8R in relation to material related party transactions and any changes therein.

 

Other information

 

The NAV per Ordinary Share has been calculated using the number of Ordinary Shares in issue at 31 May 2022, which was 101,728,082. A summary of investment changes for the six months under review and an investment portfolio summary as at 31 May 2022 are included above. A full copy of the Interim Report and Financial Statements will be printed and issued to Shareholders in due course. Copies of this announcement will be available to the public at the office of Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow, G2 2LW; at the Registered office of the Company at 1 - 2 Royal Exchange Buildings, London, EC3V 3LF; and on the Company's website at: www.mavencp.com/migvct3.

 

Neither the content of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

On behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

29 July 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BKLFLLDLLBBL
Date   Source Headline
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.